TABLE 2.

Survival at 6 months, one year and three years from time of treatment initiation in all groups combined and subgroups, including Chemo1 from time of immunotherapy initiation (line 2).

Time	Combined groups	ChemoImmuno1	Chemo1 from diagnosis	Chemo1 from time of immunotherapy start	Immuno1
6 months	81.1 (74.0, 86.4)	68.6 (48.5, 78.5)	91.1 (79.9, 96.2)	67.9 (53.9, 78.4)	78.2 (66.0, 86.5)
1 year	62.5 (54.3, 69.6)	42.9 (26.7, 58.2)	71.4 (57.6, 81.4)	44.1 (30.8, 56.6)	66.2 (52.9, 76.6)
3 years	19.1 (11.5, 28.3)	17.6 (4.5, 37.9)	20.1 (10.0, 32.7)	15.4 (6.57, 27.7)	17.9 (4.03, 39.9)